| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/28/2005 | US20050164256 Treating and/or preventing cornary heart defects via administration of forkhead transcription factor; gene therapy |
| 07/28/2005 | US20050164251 Novel human transporter proteins and polynucleotides encoding the same |
| 07/28/2005 | US20050164250 Compositions and methods for the diagnosis and treatment of tumor |
| 07/28/2005 | US20050164248 Compositions isolated from bovine tissues and methods for their use |
| 07/28/2005 | US20050164247 isolated nucleic acid molecule wherein CD4+T cells over-expressing said nucleic acid sequence exhibits a reduction in CD3 and CD28 mediated T-cell proliferation; vector and host cell transformed with said nucleic acid |
| 07/28/2005 | US20050164237 Novel manganese superoxide dismutase regulatory elements and uses therefore |
| 07/28/2005 | US20050164232 Reg-like protein |
| 07/28/2005 | US20050164222 Optimization of immunomodulatory properties of genetic vaccines |
| 07/28/2005 | US20050164221 Novel human membrane proteins and polynucleotides encoding the same |
| 07/28/2005 | US20050164206 For use in gene therapy |
| 07/28/2005 | US20050164202 Nucleotide sequences coding junctophilin-like polypeptides (JPL) to prevent ad treat cell proliferative disorders; antitumor agents; anticarcinogenic agents; tissue targeted therapy; immunotherapeutics |
| 07/28/2005 | US20050164201 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses therof |
| 07/28/2005 | US20050164197 Using matrix protein concentration to detect liver, cardiovascular and kidney disorders |
| 07/28/2005 | US20050164194 Growth regulating proteins |
| 07/28/2005 | US20050164185 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta |
| 07/28/2005 | US20050164183 Adipocyte differentiation-associated gene and protein |
| 07/28/2005 | US20050164182 Nucleoside comprising reporter molecule cleavable by hydrolase such as esterases, phosphatases, peptidases, penicillin amidases, glycosidases, and phosphorylases; limits polymerase activity; sequencing; solid phase synthesis |
| 07/28/2005 | US20050164179 Androgen receptor coactivators |
| 07/28/2005 | US20050164176 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines |
| 07/28/2005 | US20050164175 Respiratory Syncytial Virus; vectors containing heterogeneity genes |
| 07/28/2005 | US20050164171 High-throughput assay for virus entry and drug screening |
| 07/28/2005 | US20050164164 Hiv-1 virus tat-protein mutants |
| 07/28/2005 | US20050164163 Helicase inhibitors; enzyme inhibitor; viricides agent; mimetics |
| 07/28/2005 | US20050163816 Gas-plasma treatment of a substrate of medical implant; living cells coupled to a treated substrate may produce more of a growth factor than living cells coupled to an untreated substrate |
| 07/28/2005 | US20050163807 complex comprising the attenuated verotoxin or its A subunit with a ligand that specifically and selectively binds to a cancer cell, and an anticancer agent comprising the complex as an active ingredient |
| 07/28/2005 | US20050163805 Orthopoxvirus vectors, genes and products thereof |
| 07/28/2005 | US20050163804 Containing transcriptional units which encode a signal sequence of one flavivirus and an immunogenic flavivirus antigen of a second flavivirus; Japanese encephalitis virus (JEV), West Nile virus (WNV) or related flaviviruses |
| 07/28/2005 | US20050163799 Ditetics; useful for decreasing the amount of insulin necessary for the treatment of diabetes; Fc immunoglobulin region, derivative or analog fused to the N-terminal portion of the OB protein, derivative or analog |
| 07/28/2005 | US20050163798 Fusion polypeptide capable of binding vascular endothelial growth factor (VEGF) to patient in need thereof, wherein polypeptide consists of immunoglobulin-like (Ig) domain 2 of a first VEGF receptor and Ig domain 3 of a second VEGF receptor and a multimerizing component; eye disorders |
| 07/28/2005 | US20050163797 Also comprises neuroactive compounds, hormones, compounds having growth hormone acitivity, and polypeptide; vaccines; selected HCV antigens together with the polyamino acid adjuvants, especially polyarginine, and optionally the immunogenic compounds |
| 07/28/2005 | US20050163796 Decapeptide immunogen able inducing cytotoxic lymphocytes, is used to provide a protection against an HIV infection; biodrugs |
| 07/28/2005 | US20050163795 IHNV G protein for immune stimulation |
| 07/28/2005 | US20050163794 Immunological herpes simplex virus antigens and methods for use thereof |
| 07/28/2005 | US20050163793 Methods for recovering peptides from stress protein-peptide complexes |
| 07/28/2005 | US20050163792 Stress protein joined to another component, such as a fusion protein in which a stress protein is fused to an antigen |
| 07/28/2005 | US20050163791 Brachyspira hyodysenteriae vaccine |
| 07/28/2005 | US20050163788 Prevention and treatment of amyloidogenic disease |
| 07/28/2005 | US20050163786 Compounds and methods for modulating adhesion molecule function |
| 07/28/2005 | US20050163781 uses of inhibitors against hypoxia-induced genes for the manufacture of a medicament to prevent and/or to suppress post-operative/post-wounding adhesions formation; peritoneal or pelvic cavities resulting from wound, surgery, infection, inflammation or trauma |
| 07/28/2005 | US20050163780 Administering antagonist of a GP39, selected from an antibody which specifically bind GP39, soluble CD40 and soluble CD40 fusion proteins |
| 07/28/2005 | US20050163779 smooth muscle growth inhibitory composition comprising adipose tissue-specific secretory factor apM1 (adipose most abundant gene transcript 1) as an active ingredient; diagnostic agent comprising an antibody against the adipose tissue-specific secretory factor apM1 |
| 07/28/2005 | US20050163776 Treatment of tse infection |
| 07/28/2005 | US20050163772 B7S1: an immune modulator |
| 07/28/2005 | US20050163767 useful as a diagnostic marker or a drug target for bronchial asthma, chronic obstructive pulmonary disease; isolated antibody which specifically binds to a specific protein belonging to the chitinase family |
| 07/28/2005 | US20050163766 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/28/2005 | US20050163760 sustained delivery of a molecule to the central nervous system; bioavailability; population of cells enriched in hematopoietic stem or progenitor or stem cells capable of migrating to the CNS upon administration |
| 07/28/2005 | US20050163758 Tumor/cancer therapy/drugs for infecting/killing cells with mutant virus; comprises deletion or inactivating mutation in both copies of gene, at least one copy is reintroduced under transcriptional control of cell-specific and/or tumor-specific promoter; capable of delivering transgene cytotoxic to tumor |
| 07/28/2005 | US20050163755 Methods and compositions related to 1-caldesmon |
| 07/28/2005 | US20050163750 Methods of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby |
| 07/28/2005 | US20050163747 Heteromultimeric TNF ligand family members |
| 07/28/2005 | US20050163746 Heat shock proteins (HSP) activate lymphocytes to produce immunomodulatory cytokines and influence cytokines, chemokines, and surface antigens; drug screening |
| 07/28/2005 | US20050163744 Novel method for down-regulation of amyloid |
| 07/28/2005 | US20050163728 A mixture of polypeptides, as calcium binding protein for reducing bone loss and reducing renal phosphate excretion; biodrug for treating bone disorders; injectable solution or dispersed in toothpaste or a mouthwash or gum patch |
| 07/28/2005 | US20050163710 Gastrin receptor-avid peptide conjugates |
| 07/28/2005 | US20050163709 Development of DNA probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes |
| 07/28/2005 | US20050162187 Programmable I/O element circuit for high speed logic devices |
| 07/28/2005 | US20050161631 Antifreeze proteins for inhibition of clathrate hydrate formation and reformation |
| 07/28/2005 | US20050161056 Modifying nicotine and nitrosamine levels in tobacco |
| 07/28/2005 | DE10361268A1 Verfahren zur fermentativen Herstellung von L-Aminosäuren unter Verwendung von Stämmen der Familie Enterobacteriaceae A process for the fermentative preparation of L-amino acids using strains of the family Enterobacteriaceae |
| 07/28/2005 | DE10361192A1 Verfahren zur fermentativen Herstellung von L-Aminosäuren unter Verwendung von Stämmen der Familie Enterobacteriaceae A process for the fermentative preparation of L-amino acids using strains of the family Enterobacteriaceae |
| 07/28/2005 | DE10360456A1 Tumorantigene und deren Verwendung Tumor antigens and the use thereof |
| 07/28/2005 | DE10359661A1 Genvarianten die für Proteine aus dem Stoffwechselweg von Feinchemikalien codieren Gene variants which encode proteins from the metabolic pathway of fine chemicals |
| 07/28/2005 | DE10359595A1 Pgro-Expressionseinheiten Pgro expression units |
| 07/28/2005 | DE10359594A1 PEF-TU-Expressionseinheiten PEF-TU-expression units |
| 07/28/2005 | DE10318087B4 Genetische Kontrolle von Blühzeitpunkt und Pathogenbefall in Pflanzen Genetic control of flowering time and pathogen attack in plants |
| 07/28/2005 | DE102004059633A1 Promotoren und deren Verwendung Promoters and their use |
| 07/28/2005 | CA2559379A1 Process for producing human serum albumin by heating in presence of divalent cation |
| 07/28/2005 | CA2554001A1 Epitope/peptide recognized by hla-a2402-restricted ep-cam-specific ctl and use of the same |
| 07/28/2005 | CA2553947A1 Promoter |
| 07/28/2005 | CA2553790A1 Differentiation regulating agent containing gene regulating differentiation from stem cells into natural killer cells as effective ingredient |
| 07/28/2005 | CA2553613A1 Anticariogenic proteins & peptides & saccharides |
| 07/28/2005 | CA2553609A1 Methods and compositions for modulating a steroid receptor |
| 07/28/2005 | CA2553377A1 Gene therapy for tumors using minus-strand rna viral vectors encoding immunostimaulatory cytokines |
| 07/28/2005 | CA2553336A1 Integrase fusion proteins and their use with integrating gene therapy |
| 07/28/2005 | CA2553172A1 Methods and system for the identification and characterization of peptides and their functional relationships by use of measures of correlation |
| 07/28/2005 | CA2552947A1 Chimera botulinum toxin type e |
| 07/28/2005 | CA2551126A1 Toxin complex proteins and genes from xenorhabdus bovienii |
| 07/28/2005 | CA2551082A1 Hiv gp41 hr2-derived synthetic peptides, and their use in therapy to inhibit transmission of human immunodeficiency virus |
| 07/28/2005 | CA2547511A1 Recombinant icosahedral virus like particle production in pseudomonads |
| 07/28/2005 | CA2546319A1 Production of glucagon like peptide 2 and analogs |
| 07/28/2005 | CA2514395A1 Methods and compositions for the inhibition of cathepsins |
| 07/27/2005 | WO2005067410A2 Synthetic nucleic acids from aquatic species |
| 07/27/2005 | EP1557467A1 Expression system derived from the lipase regulation cascade of Pseudomonas alcaligenes |
| 07/27/2005 | EP1557466A1 Tumor antigen protein and utilization thereof |
| 07/27/2005 | EP1557465A1 Cap-binding protein |
| 07/27/2005 | EP1557432A2 Hybrid proteins which form heterodimers |
| 07/27/2005 | EP1557431A1 Assay and reagents for quantifying hBNP |
| 07/27/2005 | EP1557429A1 Site-directed coupling of proteins |
| 07/27/2005 | EP1557428A1 Antibodies against a human stromal derived factor (SDF) and pharmaceutical composition containing them |
| 07/27/2005 | EP1557427A2 Hedgehog protein conjugate |
| 07/27/2005 | EP1557426A2 45 human secreted proteins |
| 07/27/2005 | EP1557425A2 123 human secreted proteins |
| 07/27/2005 | EP1557178A1 Use of sglt homolog |
| 07/27/2005 | EP1557173A1 Soluble CTLA4 mutant molecules and uses thereof |
| 07/27/2005 | EP1557085A1 Mouse model for human psoriasis |
| 07/27/2005 | EP1557084A2 Method of producing recombinant proteins in the mammary gland of non-transgenic mammals |
| 07/27/2005 | EP1556697A1 Means and methods for diagnosing a treponema infection |
| 07/27/2005 | EP1556694A2 Method of isolation and self-assembly of small protein particles from blood and other biological materials |
| 07/27/2005 | EP1556518A2 Genes and polypeptides relating to human pancreatic cancers |
| 07/27/2005 | EP1556516A2 HUMAN TYPE II DIABETES GENE-SLIT-3 LOCATED ON CHROMOSOME 5q35 |